Entrada Therapeutics Stock Forecast - Accumulation Distribution
| TRDA Stock | USD 6.54 0.15 2.35% |
Entrada Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Entrada Therapeutics stock prices and determine the direction of Entrada Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Entrada Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
The current year's Payables Turnover is expected to grow to 28.80, whereas Receivables Turnover is forecasted to decline to 31.69. . As of July 26, 2025, Common Stock Shares Outstanding is expected to decline to about 30.6 M. The current year's Net Loss is expected to grow to about (80.9 M). Open Interest Against 2025-09-19 Entrada Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Entrada Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Entrada Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Entrada Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Entrada Therapeutics' open interest, investors have to compare it to Entrada Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Entrada Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Entrada. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 5510.65 | 0.0456 |
| Check Entrada Therapeutics Volatility | Backtest Entrada Therapeutics | Information Ratio |
Entrada Therapeutics Trading Date Momentum
| On July 26 2025 Entrada Therapeutics was traded for 6.54 at the closing time. The top price for the day was 6.58 and the lowest listed price was 6.28 . There was no trading activity during the period 0.0. Lack of trading volume on July 26, 2025 did not affect price variability. The overall trading delta against the current closing price is 2.14% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Entrada Therapeutics to competition |
Other Forecasting Options for Entrada Therapeutics
For every potential investor in Entrada, whether a beginner or expert, Entrada Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Entrada Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Entrada. Basic forecasting techniques help filter out the noise by identifying Entrada Therapeutics' price trends.Entrada Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Entrada Therapeutics stock to make a market-neutral strategy. Peer analysis of Entrada Therapeutics could also be used in its relative valuation, which is a method of valuing Entrada Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Entrada Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Entrada Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Entrada Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Entrada Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Entrada Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Entrada Therapeutics shares will generate the highest return on investment. By undertsting and applying Entrada Therapeutics stock market strength indicators, traders can identify Entrada Therapeutics entry and exit signals to maximize returns.
Entrada Therapeutics Risk Indicators
The analysis of Entrada Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Entrada Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting entrada stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.57 | |||
| Standard Deviation | 3.42 | |||
| Variance | 11.73 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Entrada Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Entrada Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Entrada Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Entrada Therapeutics Stock:Check out Historical Fundamental Analysis of Entrada Therapeutics to cross-verify your projections. For information on how to trade Entrada Stock refer to our How to Trade Entrada Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entrada Therapeutics. If investors know Entrada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entrada Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.58 | Revenue Per Share | Quarterly Revenue Growth (0.65) | Return On Assets | Return On Equity |
The market value of Entrada Therapeutics is measured differently than its book value, which is the value of Entrada that is recorded on the company's balance sheet. Investors also form their own opinion of Entrada Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Entrada Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entrada Therapeutics' market value can be influenced by many factors that don't directly affect Entrada Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entrada Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Entrada Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entrada Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.